Acyclovir Tablets USP 800 mg — Class II drug recall D-017-2014
Terminated recall by Apotex Inc., reported 2013-12-04, distributed nationwide. Presence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile rubber glo
| Recall number | D-017-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Apotex Inc., Toronto, N/A, Canada |
| Recall initiated | 2013-07-17 |
| Classified | 2013-11-22 |
| Reported by FDA | 2013-12-04 |
| Terminated | 2014-08-04 |
| Distributed | Nationwide (US) |
| Quantity | 4,844 bottles |
| Reason classes | specification failure |
| NDC | 60505-5306, 60505-5306-01, 60505-5306-03, 60505-5306-05, 60505-5306-08, 60505-5307, 60505-5307-01, 60505-5307-03, 60505-5307-05 |
| Lot numbers | 07/15, KF2199 |
Product
Acyclovir Tablets USP 800 mg ,(NDC 60505-5307-1), Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for Apotex Corp.,Weston, Florida 33326.
Reason for recall
Presence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile rubber glove embedded within the tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-017-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.